Citadel Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.3K Sell
220,100
-471,000
-68% -$740K ﹤0.01% 12231
2025
Q4
$2.14M Buy
691,100
+406,400
+143% +$1.16M ﹤0.01% 5778
2025
Q3
$749K Buy
284,700
+198,600
+231% +$438K ﹤0.01% 8182
2025
Q2
$106K Buy
86,100
+17,700
+26% +$19.3K ﹤0.01% 11287
2025
Q1
$75.2K Sell
68,400
-54,100
-44% -$62.5K ﹤0.01% 11827
2024
Q4
$111K Buy
122,500
+27,800
+29% +$23.8K ﹤0.01% 11327
2024
Q3
$93.4K Sell
94,700
-16,800
-15% -$16.2K ﹤0.01% 11217
2024
Q2
$100K Buy
111,500
+12,600
+13% +$9.43K ﹤0.01% 10916
2024
Q1
$117K Sell
98,900
-11,500
-10% -$12.7K ﹤0.01% 11142
2023
Q4
$101K Sell
110,400
-3,100
-3% -$2.29K ﹤0.01% 10934
2023
Q3
$94.5K Buy
113,500
+35,800
+46% +$41.3K ﹤0.01% 10970
2023
Q2
$93.2K Buy
77,700
+29,000
+60% +$36.1K ﹤0.01% 11041
2023
Q1
$61.4K Sell
48,700
-111,700
-70% -$214K ﹤0.01% 11898
2022
Q4
$348K Sell
160,400
-139,800
-47% -$1.15M ﹤0.01% 8991
2022
Q3
$3.6M Sell
300,200
-36,200
-11% -$449K ﹤0.01% 4453
2022
Q2
$2.82M Sell
336,400
-158,700
-32% -$1.23M ﹤0.01% 4872
2022
Q1
$4.3M Buy
495,100
+473,000
+2,140% +$4.56M ﹤0.01% 4472
2021
Q4
$250K Buy
22,100
+4,200
+23% +$49.9K ﹤0.01% 11353
2021
Q3
$225K Sell
17,900
-2,700
-13% -$24.9K ﹤0.01% 11727
2021
Q2
$167K Sell
20,600
-21,900
-52% -$190K ﹤0.01% 12386
2021
Q1
$393K Buy
42,500
+20,300
+91% +$205K ﹤0.01% 10223
2020
Q4
$215K Buy
+22,200
New +$219K ﹤0.01% 9627
2020
Q3
Sell
-28,400
Closed -$369K 10303
2020
Q2
$369K Buy
28,400
+16,300
+135% +$205K ﹤0.01% 7578
2020
Q1
$123K Sell
12,100
-5,400
-31% -$70.5K ﹤0.01% 8468
2019
Q4
$274K Buy
17,500
+400
+2% +$8.06K ﹤0.01% 7730
2019
Q3
$287K Buy
+17,100
New +$340K ﹤0.01% 7614

Other funds holding GOSS